Ameriprise Financial Inc Precision Biosciences Inc Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$4.65 - $8.73 $55,381 - $103,974	-11,910 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.66 - $8.7 $121,439 - $226,721	-26,060 Reduced 68.63%	11,910 $99,000
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $5,529 - $16,435	-1,095 Reduced 2.8%	37,970 $230,000
Q4 2019 Feb 14, 2020	SELL	$6.32 - $19.66 $1.56 Million - $4.84 Million	-246,153 Reduced 86.3%	39,065 $545,000
Q3 2019 Nov 14, 2019	SELL	$8.03 - $14.82 $63,155 - $116,559	-7,865 Reduced 2.68%	285,218 $2.39 Million
Q2 2019 Aug 14, 2019	BUY	$11.88 - $16.94 $511,826 - $729,826	43,083 Added 17.23%	293,083 $3.88 Million
Q1 2019 May 15, 2019	BUY	$17.44 - $17.95 $4.36 Million - $4.49 Million	250,000 New	250,000 $4.49 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $553M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.